Latest Anticoagulants Stories
Results Add to Findings from Ongoing Five-Year Post-Marketing Safety Program of XARELTO® Use in Clinical Practice NATIONAL HARBOR, Md., May 15, 2015 /PRNewswire/ -- New data from an ongoing
RnRMarketResearch.com adds “Pulmonary Embolism – Pipeline Review, H1 2015” to its store.
NEW YORK, April 21, 2015 /PRNewswire/ -- The New York City law firm of Rheingold, Valet, Rheingold, McCartney & Giuffra LLP this week commenced two wrongful death lawsuits, each involving
-- Data show initial therapy in newly diagnosed NVAF patients diverged from guideline recommendations RIDGEFIELD, Conn., March 16, 2015 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals,
The San Diego based law firm with its national network of experienced lawyers comments on the FDA's Adverse Reaction changes to the anticoagulant's labeling, as well as the development
TOKYO and PARSIPPANY, N.J., Feb.
Xarelto Bleeding Lawsuits Filed In Federal And State Courts Allege The Prescription Blood Thinner Causes Uncontrollable Or Fatal Bleeding Due To The Lack Of An Antidote Columbus,
The study comes as dozens of plaintiffs, including a number being represented by the Firm, pursue Xarelto lawsuits after allegedly suffering uncontrollable bleeding and other complications due
Findings Add to Rigorous Post-Marketing Safety Program for XARELTO® in Routine Clinical Practice RARITAN, N.J., Jan.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.